- Country: Czech Republic
- Summary: Endocrine Therapy
- CZT Ref No: 105774265
- Deadline: 16 Sep 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 1848500
- Notice Type: Tender
- Document Ref. No.: 491146-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the performance of this public contract is the provision of ongoing partial deliveries of medicinal products for endocrine therapy for the Na Homolce Hospital pharmacy, for the duration of the framework agreement from the date of its entry into force.
L02BA03 FULVESTRANT INJ SOL 250MG/5ML
L02BB04 ENZALUTAMIDE TBL FLM/CPS - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINEndocrine Therapy - Czech Tender
The HOSPITAL NA HOMOLCE, a Government sector organization in Czech Republic, has announced a new tender for Endocrine Therapy. This tender is published on CzechTenders under CZT Ref No: 105774265 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-09-16.
The estimated tender value is CZK 1848500, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
